Product Information
NYSTATIN-TRIAMCINOLONE OINTM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3178 per GM under NDC 45802024414. Its NADAC has been published 456 times since Nov 29, 2017.
FDA first approved this application on Dec 20, 2016. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802024414
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207380FDA Approved
12/20/2016
TE Code
AT
On Market Since
10/18/2017
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE OINTM has been published 456 times since Nov 29, 2017, and over the history we have for it it has declined 86.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3178 per GM |
|---|---|
| All-time high | $3.2553 (Mar 14, 2018) |
| All-time low | $0.2317 (May 22, 2024) |
| 52-week high | $0.3817 |
| 52-week low | $0.2997 |
| Median price | $0.4277 |
| Average price | $0.6106 |
| Largest weekly change | +125.8% (Feb 21, 2018) |
| Weeks tracked | 456 |
| Tracking since | Nov 29, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE OINTM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE OINTM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3178 per GM (NDC 45802024414), effective Aug 19, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE OINTM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has declined 86.9%. It has been tracked across 456 weekly CMS publications since Nov 29, 2017.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE OINTM?
Since Nov 29, 2017, the NADAC for NYSTATIN-TRIAMCINOLONE OINTM has ranged from a low of $0.2317 (May 22, 2024) to a high of $3.2553 (Mar 14, 2018), with a median of $0.4277 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE OINTM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE OINTM, is $0.2266 per GM — about 29% below NYSTATIN-TRIAMCINOLONE OINTM.
Who manufactures NYSTATIN-TRIAMCINOLONE OINTM?
NYSTATIN-TRIAMCINOLONE OINTM (NDC 45802024414) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.